Ronen Marmorstein

Active 1992–2025

131
Papers
20,873
Citations
86
h-index
129
i10-index

Citations

Citations per year for Ronen Marmorstein1992: 11 citations1993: 30 citations1994: 22 citations1995: 21 citations1996: 17 citations1997: 30 citations1998: 22 citations1999: 68 citations2000: 139 citations2001: 157 citations2002: 142 citations2003: 128 citations2004: 155 citations2005: 116 citations2006: 170 citations2007: 188 citations2008: 218 citations2009: 200 citations2010: 215 citations2011: 254 citations2012: 235 citations2013: 237 citations2014: 284 citations2015: 220 citations2016: 233 citations2017: 196 citations2018: 235 citations2019: 613 citations2020: 815 citations2021: 727 citations2022: 514 citations2023: 444 citations2024: 744 citations2025: 327 citations2026: 14 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,049 citing papers, 33% of this breakdownChina: 1,210 citing papers, 13.1% of this breakdownUnited Kingdom: 554 citing papers, 6% of this breakdownGermany: 518 citing papers, 5.6% of this breakdownFrance: 363 citing papers, 3.9% of this breakdownCanada: 311 citing papers, 3.4% of this breakdownJapan: 266 citing papers, 2.9% of this breakdownItaly: 264 citing papers, 2.9% of this breakdownIndia: 235 citing papers, 2.5% of this breakdownAustralia: 185 citing papers, 2% of this breakdownSpain: 164 citing papers, 1.8% of this breakdownNetherlands: 150 citing papers, 1.6% of this breakdown
0%33%Other 21.3%

Fields

  • Biochemistry, Genetics and Molecular Biology59%
  • Medicine29.9%
  • Immunology and Microbiology2.9%
  • Agricultural and Biological Sciences1.7%
  • Neuroscience1.5%
  • Chemistry1.2%
  • Other3.8%

Topics

  • Epigenetics and DNA Methylation6.2%
  • Genomics and Chromatin Dynamics4.7%
  • Histone Deacetylase Inhibitors Research4.6%
  • Ubiquitin and proteasome pathways4.2%
  • Protein Degradation and Inhibitors3.1%
  • Autophagy in Disease and Therapy2.8%
  • Other74.4%

Coauthors

All papers

Open in search
  1. Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David McElligott, Ed Kesicki, Ronen Marmorstein, Chaohong Sun, Philip A. Cole, Saul H. Rosenberg, Michael R. Michaelides, Albert Lai, Kenneth D. Bromberg - Nature 2017 cited by 879

  2. Writers and Readers of Histone Acetylation: Structure, Mechanism, and Inhibition

    Authors: , - Cold Spring Harbor Perspectives in Biology 2014 cited by 633

  3. Autophagy mediates degradation of nuclear lamina

    Authors: , , , , , , , , , , , , , , , , , , , - Nature 2015 cited by 675

  4. Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate

    Authors: , , , , , , , , , , - Science 2009 cited by 987

  5. The MEK/ERK Network as a Therapeutic Target in Human Cancer

    Authors: , , - Molecular Cancer Research 2020 cited by 216

  6. PPT1 Promotes Tumor Growth and Is the Molecular Target of Chloroquine Derivatives in Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2018 cited by 246

  7. Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule Inhibitor

    Authors: , , , , , , , , , , , , , , , , , , - Chemistry & Biology 2010 cited by 655

  8. The copper chaperone CCS facilitates copper binding to MEK1/2 to promote kinase activation

    Authors: , , , , , , , , , , , , , , - Journal of Biological Chemistry 2021 cited by 79

  9. Characterization of histone acylations links chromatin modifications with metabolism

    Authors: , , , , , , , , , , , , , - Nature Communications 2017 cited by 220

  10. A Unified Approach to Targeting the Lysosome's Degradative and Growth Signaling Roles

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey D. Winkler, Ravi K. Amaravadi - Cancer Discovery 2017 cited by 206

  11. Structural basis for sirtuin function: What we know and what we don't

    Authors: , , - Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2009 cited by 237

  12. Structural Basis for Sirtuin Activity and Inhibition

    Authors: , - Journal of Biological Chemistry 2012 cited by 159

  13. Acetylation of the p53 DNA-Binding Domain Regulates Apoptosis Induction

    Authors: , , , , , , - Molecular Cell 2006 cited by 740

  14. Protein N-Terminal Acetylation: Structural Basis, Mechanism, Versatility, and Regulation

    Authors: , - Trends in Biochemical Sciences 2020 cited by 104

  15. DAXX represents a new type of protein-folding enabler

    Authors: , , , , , , , , - Nature 2021 cited by 91

  16. Remodelin Is a Cryptic Assay Interference Chemotype That Does Not Inhibit NAT10-Dependent Cytidine Acetylation

    Authors: , , , , , , , , , , , , , , , , , , , , , - ACS Medicinal Chemistry Letters 2020 cited by 35

  17. The structural basis of protein acetylation by the p300/CBP transcriptional coactivator

    Authors: , , , , , , - Nature 2008 cited by 445

  18. Structurally Sophisticated Octahedral Metal Complexes as Highly Selective Protein Kinase Inhibitors

    Authors: , , , , , , , , , , , , , , - Journal of the American Chemical Society 2011 cited by 237

  19. Expanding the phenotypic spectrum of NAA10-related neurodevelopmental syndrome and NAA15-related neurodevelopmental syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - European Journal of Human Genetics 2023 cited by 52

  20. Phenotypic and biochemical analysis of an international cohort of individuals with variants in NAA10 and NAA15

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Human Molecular Genetics 2019 cited by 79

  21. TXNRD1 drives the innate immune response in senescent cells with implications for age-associated inflammation

    Authors: , , , , , , , , , , , , , , , , , - Nature Aging 2024 cited by 32

  22. Structure of Human NatA and Its Regulation by the Huntingtin Interacting Protein HYPK

    Authors: , - Structure 2018 cited by 82

  23. Histone acetyltransferases: function, structure, and catalysis

    Authors: , - Current Opinion in Genetics & Development 2001 cited by 391

  24. Drugging the “Undruggable” MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Research 2021 cited by 70